https://www.pharmanow.live/latest-news/ronanrx-fda-warning-letter-glp1-compounding-misbranding-2026 2026-11-04T13:07:41+05:30 Pharma Now en 2026-11-03T00:00:00+05:30 RonanRx Faces FDA Warning Over Misleading GLP-1 Claims RonanRx https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/ronanrx-fda-warning-letter-glp1-compounding-misbranding-semaglutide-tirzepatide-202620261104130512.webp https://www.pharmanow.live/latest-news/shilpa-cdmo-50-million-peptide-manufacturing-glp1 2026-11-04T13:12:52+05:30 Pharma Now en 2026-11-03T00:00:00+05:30 Shilpa CDMO Invests $50 Million to Expand Peptide Manufacturing Shilpa https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/shilpa-cdmo-50-million-peptide-manufacturing-glp1-capacity-expansion-202620261104131208.webp https://www.pharmanow.live/latest-news/ong-tien-usa-llc-fda-warning-letter-piroxicam-dexamethasone-2026 2026-11-04T12:58:24+05:30 Pharma Now en 2026-11-03T00:00:00+05:30 Ong Tien USA LLC Faces FDA Warning Over Hidden Drug Ingredients Ong Tien https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/ong-tien-usa-fda-warning-letter-piroxicam-dexamethasone-hidden-drugs-202620261104125726.webp https://www.pharmanow.live/latest-news/fda-warning-letter-bellas-nutri-shop-hidden-opioid-nsaid-ingredients-2026 2026-11-04T12:53:03+05:30 Pharma Now en 2026-11-03T00:00:00+05:30 FDA Warns Bella's Nutri Shop Over Hidden Drug Ingredients FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-bellas-nutri-shop-warning-letter-hidden-opioid-nsaid-ingredients-202620261104125246.webp https://www.pharmanow.live/latest-news/fda-warning-letter-new-york-tong-ren-tang-unapproved-drugs-2026 2026-11-04T12:48:54+05:30 Pharma Now en 2026-11-03T00:00:00+05:30 FDA Warns New York Tong Ren Tang Over Three Unapproved Drugs FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a9eb61ce-8b4a-40d1-b483-f9709306845a/d42aac1d-8454-442c-9457-3d2d7ef00cf9.png https://www.pharmanow.live/latest-news/fda-warning-letter-new-green-nutrition-undeclared-dexamethasone-herbal-supplement 2026-11-04T12:41:11+05:30 Pharma Now en 2026-11-03T00:00:00+05:30 FDA Warns New Green Nutrition Over Undeclared Dexamethasone FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-new-green-nutrition-warning-letter-undeclared-dexamethasone-herbal-supplement-202620261104124018.webp https://www.pharmanow.live/latest-news/lupin-launches-raltegravir-600mg-tablets-us-180-day-exclusivity 2026-11-04T12:36:11+05:30 Pharma Now en 2026-11-03T00:00:00+05:30 Lupin Launches Raltegravir 600 mg Tablets in the US Market Lupin https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/lupin-raltegravir-600mg-tablets-us-launch-180-day-generic-exclusivity-202620261104123521.webp https://www.pharmanow.live/latest-news/fda-warning-letter-natuzem-unapproved-drugs-mexico-2026 2026-11-04T12:30:40+05:30 Pharma Now en 2026-11-03T00:00:00+05:30 FDA Warns Natuzem Over Three Unapproved Drugs Sold Online FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-natuzem-warning-letter-three-unapproved-drugs-mexico-202620261104122958.webp https://www.pharmanow.live/latest-news/gland-pharma-fda-approval-methylprednisolone-acetate-injectable-vials 2026-11-04T12:21:18+05:30 Pharma Now en 2026-11-03T00:00:00+05:30 Gland Pharma Wins FDA Approval for Methylprednisolone Acetate Gland https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/gland-pharma-fda-approval-methylprednisolone-acetate-injectable-suspension-vials-202620261104122038.webp https://www.pharmanow.live/latest-news/ideaya-biosciences-nda-submission-darovasertib-metastatic-uveal-melanoma 2026-11-04T12:15:57+05:30 Pharma Now en 2026-11-03T00:00:00+05:30 IDEAYA Submits Darovasertib Combination NDA for Uveal Melanoma IDEAYA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/ideaya-darovasertib-crizotinib-nda-submission-metastatic-uveal-melanoma-202620261104121533.webp https://www.pharmanow.live/latest-news/teva-discontinues-phase-2-emrusolmin-trial-futility-analysis-msa 2026-11-04T12:08:15+05:30 Pharma Now en 2026-11-03T00:00:00+05:30 Teva Ends Phase 2 Emrusolmin Trial After MSA Futility Analysis Teva https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/teva-emrusolmin-phase-2-msa-futility-analysis-202620261104120712.webp https://www.pharmanow.live/latest-news/akums-acquires-oriflame-india-manufacturing-assets-rs-56-crore-cdmo-expansion 2026-11-04T12:00:44+05:30 Pharma Now en 2026-11-03T00:00:00+05:30 Akums Buys Oriflame's India Manufacturing Business for ₹56 Crore Akums https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/akums-oriflame-india-manufacturing-business-acquisition-56-crore-cdmo-expansion-202620261104115450.webp https://www.pharmanow.live/latest-news/oryzon-gains-spanish-authorization-vivaldi-phase-ib-aml-cetlam 2026-11-04T11:27:25+05:30 Pharma Now en 2026-11-03T00:00:00+05:30 Oryzon Gains Spanish Authorization for VIVALDI Phase Ib AML Study Oryzon https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/oryzon-vivaldi-phase-1b-aml-study-spanish-authorization-iadademstat-202620261104112225.webp https://www.pharmanow.live/latest-news/karyopharm-signs-merger-ayrmid-chapter-11-selinexor 2026-11-03T12:01:49+05:30 Pharma Now en 2026-11-02T00:00:00+05:30 Karyopharm Signs Merger Agreement with Ayrmid Karyopharm https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/karyopharm-ayrmid-chapter-11-merger-selinexor-supply-202620261103120139.webp https://www.pharmanow.live/latest-news/dr-reddys-tentative-usfda-approval-generic-lenacapavir-pepfar-120-nations 2026-11-03T11:53:31+05:30 Pharma Now en 2026-11-02T00:00:00+05:30 Dr. Reddy's Wins Tentative FDA Approval for Generic Lenacapavir Dr. Reddy's https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/dr-reddys-generic-lenacapavir-tentative-fda-approval-hiv-prevention-202620261103115201.webp https://www.pharmanow.live/latest-news/fda-final-potency-assurance-guidance-cell-gene-therapy-2026 2026-11-03T11:36:40+05:30 Pharma Now en 2026-11-02T00:00:00+05:30 FDA Finalizes CGT Potency Guidance for Lifecycle-Wide Quality FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-final-potency-assurance-guidance-cell-gene-therapy-manufacturing-202620261103113555.webp https://www.pharmanow.live/latest-news/tonix-pharmaceuticals-appoints-george-lederman-evp-strategy-transformation 2026-11-03T11:30:28+05:30 Pharma Now en 2026-11-02T00:00:00+05:30 Tonix Appoints George Lederman as EVP, Strategy & Transformation Tonix https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/tonix-pharmaceuticals-george-lederman-evp-strategy-transformation-appointment-202620261103112938.webp https://www.pharmanow.live/latest-news/spektus-pharma-gebro-global-deal-actraflex-pain-drug 2026-11-03T11:02:26+05:30 Pharma Now en 2026-11-02T00:00:00+05:30 Spektus Signs Global ActraFlex Commercialisation Deal with GEBRO Spektus https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/spektus-gebro-actraflex-global-commercialisation-partnership-202620261103110213.webp https://www.pharmanow.live/latest-news/glenmark-pharmaceuticals-appoints-namita-shah-senior-vice-president-global-portfolio 2026-11-03T10:50:43+05:30 Pharma Now en 2026-11-02T00:00:00+05:30 Glenmark Elevates Namita Shah to Senior VP, Global Portfolio Glenmark https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/glenmark-namita-shah-senior-vice-president-global-portfolio-appointment-202620261103104919.webp